Newsroom Stories

School of Medicine scientists have shown that the cancer therapy known as CAR-T can be applied to multiple sclerosis (MS), an autoimmune disease of the nervous system. The findings extend the powerful tool of immunotherapy to autoimmune diseases, a class of diseases that are often debilitating and difficult to treat.

In a new book, “Voicing Politics,” Arts & Sciences’ Margit Tavits uncovers the many ways in which linguistic peculiarities of different languages can have meaningful consequences for political attitudes and beliefs around the world.

A research team that includes School of Medicine and pharmacy scientists has altered the chemical properties of fentanyl. The research holds promise for developing safer opioid drugs that still relieve pain.

Using advanced geochemical analyses, a team of scientists, including Michael Frachetti, professor of archaeology in Arts & Sciences, have uncovered new answers to decades-old questions about trade of tin throughout Eurasia during the Late Bronze Age.

Elinor Harrison, a postdoctoral fellow in physical therapy and in dance, will present a new duet choreographed for twin dance majors Ali and Juli Yaniz as part of “This is Temporary,” the 2022 WashU Dance Theatre concert.

Research from Quing Zhu’s lab at the McKelvey School of Engineering yields a novel method to use ultrasound to enhance machine learning’s ability to accurately diagnose — or rule out — ovarian cancer.

A new study by researchers at Washington University School of Medicine found that undergoing more frequent computed tomography (CT) scans was not associated with improved outcomes following lung cancer surgery.

Researchers at Washington University School of Medicine have discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.

A drug compound attacks hard-to-treat prostate cancer on several fronts, according to a School of Medicine study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor and cuts off the tumor’s ability to burn testosterone as fuel.

Washington University in St. Louis’ strategic vision, “Here and Next,” is moving into its next phase: implementation planning.